Fig. 1From: Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phaseDecision tree model structure comparing NAC to AC for cT2-4N0-1 NSCLC patientsBack to article page